MedPath

Perrigo Company

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold

Phase 3
Completed
Conditions
Nasal Congestion Associated With the Common Cold
Interventions
First Posted Date
2012-12-06
Last Posted Date
2016-04-22
Lead Sponsor
Perrigo Company
Target Recruit Count
565
Registration Number
NCT01744106
Locations
🇺🇸

ClinPoint Trials, LLC, Waxahachie, Texas, United States

🇺🇸

Bluegrass Clinical Research, Louisville, Kentucky, United States

🇺🇸

Chrysalis Clinical Research, St. George, Utah, United States

and more 8 locations

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Bioequivalency
Interventions
First Posted Date
2008-12-08
Last Posted Date
2012-03-16
Lead Sponsor
Perrigo Company
Target Recruit Count
34
Registration Number
NCT00804401

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Bioequivalency
Interventions
First Posted Date
2008-12-08
Last Posted Date
2012-03-16
Lead Sponsor
Perrigo Company
Target Recruit Count
30
Registration Number
NCT00803946

Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Bioequivalency
Interventions
First Posted Date
2008-12-08
Last Posted Date
2012-03-16
Lead Sponsor
Perrigo Company
Target Recruit Count
30
Registration Number
NCT00804440

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Bioequivalency
Interventions
First Posted Date
2008-12-08
Last Posted Date
2012-03-16
Lead Sponsor
Perrigo Company
Target Recruit Count
34
Registration Number
NCT00803764

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Bioavailability
Interventions
First Posted Date
2008-12-05
Last Posted Date
2012-03-16
Lead Sponsor
Perrigo Company
Target Recruit Count
44
Registration Number
NCT00803192

Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Bioavailability
Interventions
First Posted Date
2008-12-05
Last Posted Date
2012-03-16
Lead Sponsor
Perrigo Company
Target Recruit Count
44
Registration Number
NCT00802828
© Copyright 2025. All Rights Reserved by MedPath